PEOPLE - Changes at Novo Nordisk:
This article was originally published in Clinica
Executive Summary
Marcus Carr, founder of blood diagnostics company Hemodyne, has joined diabetes care specialist Novo Nordisk (Princeton, New Jersey) as the company's CMO for North America and as executive director for its clinical research-haemostasis group in the same region. Dr Carr is reputedly a leading expert in the field of coagulation.